Atom Investors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Atom Investors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60,000	Closed	-$5.69M	–	691
2024 Q1	$5.69M	Buy	+60,000	New	+$5.57M	0.71%	23
2021 Q4	–	Sell	-103,200	Closed	-$13M	–	424
2021 Q3	$13M	Buy	+103,200	New	+$13.3M	1.05%	13
2021 Q1	–	Sell	-20,000	Closed	-$2.82M	–	434
2020 Q4	$2.82M	Buy	+20,000	New	+$2.56M	0.28%	93

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Atom Investors's XBI Position: Q1 2026 in Review

Atom Investors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 2,183 shares — an estimated $266K sold.

Atom Investors first reported a position in XBI in Q1 2019 and held it in 21 quarters. The position peaked at $39.7M in Q3 2021. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Atom Investors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
Atom Investors sold 2,183 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $266K.
Atom Investors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 21 quarters.
Atom Investors's State Street SPDR S&P Biotech ETF position peaked at $39.7M in Q3 2021.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.